Journal ArticleOPEN ACCESS

Spironolactone in Addition to ACE Inhibition to Reduce Proteinuria in Patients with Chronic Renal Disease

  • Chrysostomou A
  • Becker G
New England Journal of Medicine (2001) 345(12) 925-926
DOI: 10.1056/nejm200109203451215
235Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

To the Editor: Angiotensin-converting–enzyme (ACE) inhibitors have been shown to reduce proteinuria and slow the progression of renal disease.1 Although to date angiotensin II has been the focus of...

Cite

CITATION STYLE

APA

Chrysostomou, A., & Becker, G. (2001). Spironolactone in Addition to ACE Inhibition to Reduce Proteinuria in Patients with Chronic Renal Disease. New England Journal of Medicine, 345(12), 925–926. https://doi.org/10.1056/nejm200109203451215

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free